These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers. Pringsheim T; Hirsch L; Gardner D; Gorman DA Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656 [TBL] [Abstract][Full Text] [Related]
9. A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics. Lee ES; Vidal C; Findling RL J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):582-605. PubMed ID: 30312108 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis. Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468 [TBL] [Abstract][Full Text] [Related]
11. Use of Antipsychotics: The Experiences, Views, and Monitoring Practices of Child and Adolescent Psychiatrists in Turkey. Çakır B; Yalın Sapmaz Ş; Kandemir H J Child Adolesc Psychopharmacol; 2021 Feb; 31(1):73-78. PubMed ID: 32614261 [No Abstract] [Full Text] [Related]
12. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Aman MG; Binder C; Turgay A J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Lamy M; Erickson CA Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163 [TBL] [Abstract][Full Text] [Related]
14. Risperidone in the management of disruptive behavior disorders. Pandina GJ; Aman MG; Findling RL J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):379-92. PubMed ID: 16958564 [TBL] [Abstract][Full Text] [Related]
16. Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders. Rizzo R; Pavone P Expert Rev Neurother; 2016 Aug; 16(8):867-74. PubMed ID: 27388494 [TBL] [Abstract][Full Text] [Related]
17. Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review. Pringsheim T; Gorman D Can J Psychiatry; 2012 Dec; 57(12):722-7. PubMed ID: 23228230 [TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. Findling RL J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763 [TBL] [Abstract][Full Text] [Related]
19. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study. Lamberti M; Siracusano R; Italiano D; Alosi N; Cucinotta F; Di Rosa G; Germanò E; Spina E; Gagliano A Paediatr Drugs; 2016 Aug; 18(4):319-29. PubMed ID: 27278054 [TBL] [Abstract][Full Text] [Related]
20. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]